A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.
作者信息
Kempker Russell R, Heinrichs M Tobias, Nikolaishvili Ketino, Sabulua Irina, Bablishvili Nino, Gogishvili Shota, Avaliani Zaza, Little Brent P, Bernheim Adam, Derendorf Hartmut, Blumberg Henry M, Vashakidze Sergo, Peloquin Charles A
机构信息
Division of Infectious Diseases, Dept of Medicine, Emory University School of Medicine, Atlanta, GA, USA
University of Florida, College of Pharmacy, Gainesville, FL, USA.
出版信息
Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.02166-2017. Print 2018 Feb.
Abstract
摘要
相似文献
1
A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.
Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.02166-2017. Print 2018 Feb.
2
Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules.
Eur Respir J. 2019 Dec 4;54(6). doi: 10.1183/13993003.00580-2019. Print 2019 Dec.
3
Linezolid in children with drug resistant tuberculosis.
Infect Dis (Lond). 2018 Nov-Dec;50(11-12):868-870. doi: 10.1080/23744235.2018.1500710. Epub 2018 Oct 8.
4
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.00648-2017. Print 2017 Jul.
5
Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.
Expert Rev Anti Infect Ther. 2016 Oct;14(10):901-15. doi: 10.1080/14787210.2016.1225498. Epub 2016 Aug 27.
6
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
Emerg Infect Dis. 2017 Oct;23(10):1731-2. doi: 10.3201/eid2310.161398. Epub 2017 Oct 17.
7
Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection.
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02164-18. Print 2019 Mar.
8
Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
EBioMedicine. 2015 Oct 21;2(11):1568-9. doi: 10.1016/j.ebiom.2015.10.014. eCollection 2015 Nov.
9
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Clin Pharmacokinet. 2010 Aug;49(8):559-65. doi: 10.2165/11532080-000000000-00000.
10
Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.01724-2016. Print 2017 Mar.
引用本文的文献
1
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.
J Antimicrob Chemother. 2025 Jul 1;80(7):1860-1868. doi: 10.1093/jac/dkaf140.
2
Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis.
BMC Infect Dis. 2024 Jan 5;24(1):50. doi: 10.1186/s12879-023-08970-x.
3
Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration.
Int J Infect Dis. 2021 Mar;104:680-684. doi: 10.1016/j.ijid.2021.01.062. Epub 2021 Feb 5.
4
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
Clin Pharmacol Ther. 2021 Apr;109(4):867-891. doi: 10.1002/cpt.2198. Epub 2021 Mar 9.
5
Distribution of Linezolid in Tuberculosis Lesions in Patients with Spinal Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00450-20.
6
Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.
PLoS One. 2019 Oct 3;14(10):e0223391. doi: 10.1371/journal.pone.0223391. eCollection 2019.
7
Linezolid-induced pure red cell aplasia: a case report and literature review.
J Int Med Res. 2018 Nov;46(11):4837-4844. doi: 10.1177/0300060518800126. Epub 2018 Oct 1.
本文引用的文献
1
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00751-17. Print 2017 Aug.
2
Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00226-17. Print 2017 Jun.
3
Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.
Antimicrob Agents Chemother. 2015;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.
4
Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.
Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.
5
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Eur Respir J. 2012 Dec;40(6):1430-42. doi: 10.1183/09031936.00022912. Epub 2012 Apr 10.
6
Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis.
Clin Infect Dis. 2012 Mar;54(6):e51-4. doi: 10.1093/cid/cir904. Epub 2011 Dec 23.
7
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
Int J Tuberc Lung Dis. 2011 Apr;15(4):502-9. doi: 10.5588/ijtld.10.0238.
8
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Crit Care Med. 2005 Jul;33(7):1529-33. doi: 10.1097/01.ccm.0000168206.59873.80.
9
Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.
J Antimicrob Chemother. 2004 Mar;53(3):441-4. doi: 10.1093/jac/dkh119. Epub 2004 Feb 12.
10
Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
Clin Pharmacokinet. 2003;42(13):1129-40. doi: 10.2165/00003088-200342130-00004.
Zotero 插件